Name | (5-methyl-1,3,4-oxadiazol-2-yl)methanamine |
---|---|
Synonyms |
5-methyl-1,3,4-oxadiazole-2-methanamine
1,3,4-OXADIAZOLE-2-METHANAMINE,5-METHYL C-(5-methyl[1,3,4]oxadiazol-2-yl)methylamine (5-Methyl-1,3,4-oxadiazol-2-yl)methanamine (5-methyl-1,3,4-oxadiazol-2-yl)methylamine |
Density | 1.192g/cm3 |
---|---|
Boiling Point | 223.048ºC at 760 mmHg |
Molecular Formula | C4H7N3O |
Molecular Weight | 113.11800 |
Flash Point | 88.697ºC |
Exact Mass | 113.05900 |
PSA | 64.94000 |
LogP | 0.53700 |
Vapour Pressure | 0.098mmHg at 25°C |
Index of Refraction | 1.502 |
Hazard Codes | Xi: Irritant; |
---|---|
HS Code | 2934999090 |
~34% 125295-22-9 |
Literature: Bristol-Myers Squibb Company Patent: US2008/4265 A1, 2008 ; Location in patent: Page/Page column 34 ; |
Precursor 1 | |
---|---|
DownStream 0 |
HS Code | 2934999090 |
---|---|
Summary | 2934999090. other heterocyclic compounds. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0% |